{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:46:16Z","timestamp":1778226376731,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Cangzhou Science and Technology Support Technology Project","award":["141302108"],"award-info":[{"award-number":["141302108"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.08.151","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T09:16:33Z","timestamp":1536657393000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198"],"prefix":"10.1016","volume":"108","author":[{"given":"Ruihuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.biopha.2018.08.151_bib0005","doi-asserted-by":"crossref","first-page":"81794","DOI":"10.18632\/oncotarget.20864","article-title":"PI3Kdelta inhibition causes feedback activation of PI3Kalpha in the ABC subtype of diffuse large B-cell lymphoma","volume":"8","author":"Pongas","year":"2017","journal-title":"Oncotarget"},{"issue":"39","key":"10.1016\/j.biopha.2018.08.151_bib0010","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007952","article-title":"Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma","volume":"96","author":"Song","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.biopha.2018.08.151_bib0015","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1517\/14656566.5.6.1321","article-title":"A review of the proteasome inhibitor in multiple myeloma","volume":"5","author":"Richardson","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2018.08.151_bib0020","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/jbmr.2741","article-title":"The proteasome inhibitor bortezomib maintains osteocyte viability in multiple myeloma patients by reducing both apoptosis and autophagy: a new function for proteasome inhibitors","volume":"31","author":"Toscani","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"15","key":"10.1016\/j.biopha.2018.08.151_bib0025","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2174\/138161211796197124","article-title":"The ubiquitin-proteasome system (UPS) and the mechanism of action of bortezomib","volume":"17","author":"Cvek","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.biopha.2018.08.151_bib0030","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1182\/blood-2005-01-0427","article-title":"The fully human anti-CD30 antibody 5F11 activates NF-{kappa}B and sensitizes lymphoma cells to bortezomib-induced apoptosis","volume":"106","author":"Boll","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.biopha.2018.08.151_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032584","article-title":"Blocking autophagy prevents bortezomib-induced NF-kappaB activation by reducing I-kappaBalpha degradation in lymphoma cells","volume":"7","author":"Jia","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2018.08.151_bib0040","first-page":"1","article-title":"Expression of TRIM28 correlates with proliferation and Bortezomib-induced apoptosis in B-cell non-Hodgkin lymphoma","author":"Zhang","year":"2018","journal-title":"Leuk. Lymphoma"},{"issue":"7006","key":"10.1016\/j.biopha.2018.08.151_bib0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2018.08.151_bib0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2018.08.151_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1397344","article-title":"Overview of microRNA biology","volume":"35","author":"Mohr","year":"2015","journal-title":"Semin. Liver Dis."},{"issue":"11","key":"10.1016\/j.biopha.2018.08.151_bib0060","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1349-7006.2010.01683.x","article-title":"The microRNA pathway and cancer","volume":"101","author":"Kwak","year":"2010","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.08.151_bib0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/path.2806","article-title":"miRNAs in human cancer","volume":"223","author":"Farazi","year":"2011","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2018.08.151_bib0070","first-page":"1117","article-title":"Circulating miRNAs: promising biomarkers of human cancer","volume":"12","author":"Qu","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"10","key":"10.1016\/j.biopha.2018.08.151_bib0075","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cbin.10139","article-title":"Bortezomib induces apoptosis of endometrial cancer cells through microRNA-17-5p by targeting p21","volume":"37","author":"Shen","year":"2013","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.biopha.2018.08.151_bib0080","first-page":"289","article-title":"The HMGA proteins: a myriad of functions (Review)","volume":"32","author":"Cleynen","year":"2008","journal-title":"Int. J. Oncol."},{"issue":"Pt A","key":"10.1016\/j.biopha.2018.08.151_bib0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijsu.2015.10.031","article-title":"HMGA1\/HMGA2 protein expression and prognostic implications in gastric cancer","volume":"24","author":"Jun","year":"2015","journal-title":"Int. J. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.151_bib0090","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3892\/ol.2015.3914","article-title":"Association of SIRT1 and HMGA1 expression in non-small cell lung cancer","volume":"11","author":"Lin","year":"2016","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2018.08.151_bib0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1566524016666160316152147","article-title":"The high mobility group A1 (HMGA1) transcriptome in Cancer and development","volume":"16","author":"Sumter","year":"2016","journal-title":"Curr. Mol. Med."},{"issue":"15","key":"10.1016\/j.biopha.2018.08.151_bib0100","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.febslet.2013.06.021","article-title":"miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1","volume":"587","author":"Lin","year":"2013","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.biopha.2018.08.151_bib0105","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1159\/000358700","article-title":"MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1","volume":"33","author":"Xu","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.151_bib0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3892\/or.2016.4797","article-title":"Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.151_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087671","article-title":"Incidence and risk of cardiotoxicity associated with bortezomib in the treatment of cancer: a systematic review and meta-analysis","volume":"9","author":"Xiao","year":"2014","journal-title":"PloS One"},{"issue":"24","key":"10.1016\/j.biopha.2018.08.151_bib0120","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","article-title":"Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma","volume":"113","author":"Dunleavy","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.biopha.2018.08.151_bib0125","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3109\/10428194.2012.656629","article-title":"Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma","volume":"53","author":"Elstrom","year":"2012","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.biopha.2018.08.151_bib0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/157016310793180648","article-title":"Versatile applications of microRNA in anti-cancer drug discovery: from therapeutics to biomarkers","volume":"7","author":"Iguchi","year":"2010","journal-title":"Curr. Drug Discov. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.151_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029541","article-title":"miR-122 regulates p53\/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma","volume":"7","author":"Manfe","year":"2012","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.biopha.2018.08.151_bib0140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/aps.2010.237","article-title":"Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-kappaB activity and miR-16-1*","volume":"32","author":"Meng","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2018.08.151_bib0145","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1038\/srep06145","article-title":"MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8","volume":"4","author":"Wang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.08.151_bib0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12957-016-0784-x","article-title":"Decreased miR-198 expression and its prognostic significance in human gastric cancer","volume":"14","author":"Cui","year":"2016","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2018.08.151_bib0155","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3892\/ol.2017.5673","article-title":"miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1","volume":"13","author":"Hu","year":"2017","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.biopha.2018.08.151_bib0160","first-page":"2287","article-title":"miR-198 regulated the tumorigenesis of gastric cancer by targeting Toll-like receptor 4 (TLR4)","volume":"22","author":"Quan","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2018.08.151_bib0165","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbrc.2016.03.040","article-title":"MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1","volume":"472","author":"Zhang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218342008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218342008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:44:27Z","timestamp":1777272267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218342008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":33,"alternative-id":["S0753332218342008"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.151","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}